Detalle Publicación

ARTÍCULO
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Autores: Reig, M. (Autor de correspondencia); Forner, A.; Rimola, J.; Ferrer-Fábrega, J.; Burrel, M.; García-Criado, A.; Kelley, R. K.; Galle, P. R.; Mazzaferro, V.; Salem, R.; Sangro Gómez-Acebo, Bruno Carlos; Singal, A. G.; Vogel, A.; Fuster, J.; Ayuso, C.; Bruix, J. (Autor de correspondencia)
Título de la revista: JOURNAL OF HEPATOLOGY (ONLINE)
ISSN: 0168-8278
Volumen: 76
Número: 3
Páginas: 681 - 693
Fecha de publicación: 2022
Lugar: WOS
Resumen:
There have been major advances in the armamentarium for hepatocellular carcinoma (HCC) since the last official update of the Barcelona Clinic Liver Cancer prognosis and treatment strategy published in 2018. Whilst there have been advances in all areas, we will focus on those that have led to a change in strategy and we will discuss why, despite being encouraging, data for select interventions are still too immature for them to be incorporated into an evidence-based model for clinicians and researchers. Finally, we describe the critical insight and expert knowledge that are required to make clinical decisions for individual patients, considering all of the parameters that must be considered to deliver personalised clinical management.